BOSTON, Sept. 30, 2021 /PRNewswire/ -- Ginkgo
Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which
is building the leading horizontal platform for cell programming,
announced today that management is scheduled to participate in the
following upcoming conferences:
- A panel at the Cowen Annual MedTools Conference
on Thursday, October 7, 2021, at
11:15 a.m. Eastern Time.
- A fireside chat and 1x1 meetings at the Morgan Stanley
Annual Spark Conference on Wednesday, October 13, 2021, at 5:45 p.m. Eastern Time.
Further details, webcast links, and replays of the
presentations, if recorded, will be available on the
company's investor relations website at
https://investors.ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization and therapeutics discovery. For more information,
visit www.ginkgobioworks.com.
Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of the federal securities laws. These
forward-looking statements generally are identified by the words
"believe," "project," "potential," "expect," "anticipate,"
"estimate," "intend," "strategy," "future," "opportunity," "plan,"
"may," "should," "will," "would," "will be," "will continue," "will
likely result," and similar expressions. Forward-looking statements
are predictions, projections and other statements about future
events that are based on current expectations and assumptions and,
as a result, are subject to risks and uncertainties. Many factors
could cause actual future events to differ materially from the
forward-looking statements in this document, including but not
limited to: (i) the effect of the business combination with Soaring
Eagle Acquisition Corp. ("Soaring Eagle") on Ginkgo's
business relationships, performance, and business generally, (ii)
risks that the business combination disrupts current plans of
Ginkgo and potential difficulties in Ginkgo's employee retention,
(iii) the outcome of any legal proceedings that may be instituted
against Ginkgo related to its business combination with Soaring
Eagle, (iv) volatility in the price of Ginkgo's
securities now that it is a public company due to a variety of
factors, including changes in the competitive and highly regulated
industries in which Ginkgo plans to operate, variations in
performance across competitors, changes in laws and regulations
affecting Ginkgo's business and changes in the combined capital
structure, (v) the ability to implement business plans, forecasts,
and other expectations after the completion of the business
combination, and identify and realize additional opportunities, and
(vi) the risk of downturns in demand for products using synthetic
biology. The foregoing list of factors is not exhaustive. You
should carefully consider the foregoing factors and the other risks
and uncertainties described in the "Risk Factors" section of
Ginkgo's current report on Form 8-K filed with the
U.S. Securities and Exchange Commission (the "SEC") on
September 20, 2021 and other
documents filed by Ginkgo from time to time with the SEC. These
filings identify and address other important risks and
uncertainties that could cause actual events and results to differ
materially from those contained in the forward-looking statements.
Forward-looking statements speak only as of the date they are made.
Readers are cautioned not to put undue reliance on forward-looking
statements, and Ginkgo assumes no obligation and does not intend to
update or revise these forward-looking statements, whether as a
result of new information, future events, or otherwise. Ginkgo does
not give any assurance that it will achieve its expectations.
MEDIA CONTACT:
press@ginkgobioworks.com
INVESTOR CONTACT:
investors@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301388657.html
SOURCE Ginkgo Bioworks